Home/Investors/Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Biotech Investor · 2 portfolio companies

Portfolio

Combined Value

$35.0B

Focus Areas

Top Stage

Launched

Investment Focus

Company	Stage	Valuation	Focus
Ratiopharm	Launched	$35.0B	Pain Management, Respiratory Health
Mepha	Commercial	—	Broad Generic Portfolio (Cardiology, CNS, Respiratory, Oncology, Anti-infectives, etc.)